Viewing nowCombinationZaglozin 10/100 mg
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.

MFDS item code 202200064 · Approved 2022.01.04 · Insurance code 054801510
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps type 2 diabetes patients control blood sugar levels more effectively when used in conjunction with meal planning and exercise. It assists in the stable management of blood sugar levels by co-administering sitagliptin and dapagliflozin. Therefore, this medication is used for the treatment of type 2 diabetes.
One tablet of this medicine may be administered once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. Special populations Patients with renal impairment The efficacy and safety of this medicine depend on renal function; evaluation of renal function before treatment and periodically after starting treatment is recommended. - No dose adjustment is necessary when the estimated glomerular filtration rate[estimated glomerular filtration rate(eGFR)] is 45 mL/min/1.73m2 or higher. - This medicine should not be administered when the estimated glomerular filtration rate(eGFR) is below 45 mL/min/1.73 m2. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication may cause allergic reactions, so patients with a history of allergy to this medication or its components should not take it. If symptoms such as skin rash, difficulty breathing, swelling of the face or neck occur after administration, the medication should be stopped immediately and a doctor consulted. Acute pancreatitis, a serious inflammation of the pancreas, may occur, so if symptoms such as abdominal pain, vomiting, and loss of appetite arise during treatment, healthcare professionals should be notified immediately. Patients with impaired kidney function or those undergoing dialysis may require dosage adjustments and in some cases should avoid taking this medication. Patients at risk of dehydration or low blood pressure, especially the elderly or those on diuretics, should regularly check their blood pressure and fluid status before and during treatment. There is a risk of hypoglycemia; therefore, if taken together with insulin or sulfonylureas, dosage adjustments may be necessary. The risk of genital infections and urinary tract infections may increase, so patients should seek treatment immediately if infection symptoms appear. Pregnant or nursing women are advised not to use this medication, and it should be discontinued if pregnancy is confirmed. Safety and efficacy have not been established for children and adolescents under 18, so it should not be used in this population. There is no specific antidote for overdose, so patients should go to the hospital immediately for appropriate treatment, and the possibility of removal through dialysis is low. Caution is advised when driving or operating machinery during treatment, especially since symptoms of hypoglycemia may occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, ideally at room temperature between 1 and 30 degrees Celsius. Storing it in this manner helps maintain the medication's effectiveness and guarantees safe use.
Bright yellow rectangular film-coated tablet
Box - 28 tablets per box [(7 tablets/Alu-Alu x 4)], Box - 30 tablets per box [(10 tablets/Alu-Alu x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.